Fmoc-Lys(Boc)-OH-13C6

Fmoc-Lys(Boc)-OH-13C6 is chemically (2S)-6-(Tert-Butoxycarbonylamino)-2-[[[(9H-fluoren-9-yl)methoxy]carbonyl]amino]hexanoic acid-13C6; (S)-2-[[[(9H-Fluoren-9-yl)methoxy]carbonyl]amino]-6-(tert-butoxycarbonylamino)hexanoic acid-13C6; (S)-6-[(tert-Butoxycarbonyl)amino]-2-[[[(9H-fluoren-9-yl)methoxy]carbonyl]amino]hexanoic acid-13C6; Fmoc-L-Lys (Boc)-OH-13C6; Fmoc-L-Lys(Boc)-OH-13C6; N-α-(Fmoc)-N-ε-(t-boc)-L-Lysine-OH-13C6; N-α-Fluorenylmethoxycarbonyl-N-ε-tert-butoxycarbonyl-L-lysine-13C6; NSC 334302-13C6; Nα-(9-Fluorenylmethoxycarbonyl)-Nε-(tert-butoxycarbonyl)lysine-13C6; N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-L-lysine-13C6. Fmoc-Lys(Boc)-OH-13C6 is supplied with detailed characterization data compliant with regulatory guideline. Fmoc-Lys(Boc)-OH-13C6 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Paclitaxel.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.